SRx Health Solutions Cancels an Additional 350,000 Shares, Increasing the Total Number of Shares Canceled to Over 19 Million
SRx Health Solutions (NYSE American: SRXH) has announced the cancellation of an additional 350,000 shares, bringing the total shares canceled to over 19 million. The cancellation is part of a Settlement, Share Forfeiture and Mutual Release Agreement with certain founders and former officers of its Canadian subsidiary.
The forfeited shares were originally issued during the acquisition of SRx Canada. While the company has agreed to release specific claims against parties involved in the settlement, it maintains the right to pursue legal action against former SRx Canada officers who are not part of the agreement to recover stockholder value.
SRx Health Solutions (NYSE American: SRXH) ha annunciato la cancellazione di ulteriori 350.000 azioni, portando il totale delle azioni cancellate a oltre 19 milioni. La cancellazione rientra in un Accordo di Transazione, Confisca di Azioni e Rilascio Reciproco con alcuni fondatori e ex dirigenti della sua controllata canadese.
Le azioni confiscate erano state emesse in occasione dell'acquisizione di SRx Canada. Pur rinunciando a determinate pretese nei confronti delle parti coinvolte nell'accordo, la società si riserva il diritto di intraprendere azioni legali contro gli ex dirigenti di SRx Canada non inclusi nell'intesa per tutelare il valore per gli azionisti.
SRx Health Solutions (NYSE American: SRXH) ha anunciado la cancelación de otras 350.000 acciones, lo que eleva el total de acciones canceladas a más de 19 millones. La cancelación forma parte de un Acuerdo de Liquidación, Pérdida de Acciones y Liberación Mutua con ciertos fundadores y exdirectivos de su filial canadiense.
Las acciones perdidas se emitieron originalmente durante la adquisición de SRx Canada. Aunque la compañía ha acordado renunciar a reclamaciones concretas contra las partes incluidas en el acuerdo, se reserva el derecho a emprender acciones legales contra los exdirectivos de SRx Canada que no forman parte del acuerdo para recuperar el valor para los accionistas.
SRx Health Solutions (NYSE American: SRXH)� 추가� 350,000�� 소각하여 � 소각 주식 수가 1,900� �� 넘었다고 발표했습니다. � 소각은 캐나� 자회� 일부 창업� � 전임 임원들과� 합의�(합의, 주식 몰수 � 상호 면책 합의)� 일환입니�.
몰수� 주식은 원래 SRx Canada 인수 과정에서 발행� 것이었습니다. 회사� 합의� 포함� 당사자들� 대� 특정 청구� 포기하기� 했지�, 합의� 포함되지 않은 � SRx Canada 임원들을 상대� 주주 가치를 회복하기 위한 법적 조치� 취할 권리� 보유하고 있습니다.
SRx Health Solutions (NYSE American: SRXH) a annoncé l'annulation de 350 000 actions supplémentaires, portant le total des actions annulées à plus de 19 millions. Cette annulation s'inscrit dans le cadre d'un accord de règlement, de confiscation d'actions et de libération mutuelle avec certains fondateurs et anciens dirigeants de sa filiale canadienne.
Les actions confisquées avaient été émises lors de l'acquisition de SRx Canada. Bien que la société accepte de renoncer à des réclamations spécifiques contre les parties impliquées dans l'accord, elle se réserve le droit d'engager des poursuites contre d'anciens dirigeants de SRx Canada qui ne sont pas parties à l'accord afin de préserver la valeur pour les actionnaires.
SRx Health Solutions (NYSE American: SRXH) hat die Streichung weiterer 350.000 Aktien angekündigt, womit die insgesamt gestrichenen Aktien auf über 19 Millionen steigen. Die Streichung erfolgt im Rahmen einer Vereinbarung über Vergleich, Aktienverfall und gegenseitigen Verzicht mit bestimmten Gründern und ehemaligen leitenden Angestellten der kanadischen Tochtergesellschaft.
Die verfallenen Aktien wurden ursprünglich im Zuge der Übernahme von SRx Canada ausgegeben. Während das Unternehmen auf bestimmte Ansprüche gegen an der Einigung beteiligte Parteien verzichtet hat, behält es sich das Recht vor, rechtliche Schritte gegen ehemalige SRx Canada-Führungskräfte einzuleiten, die nicht Teil der Vereinbarung sind, um den Aktionärswert wiederherzustellen.
- Cancellation of over 19 million shares reduces share dilution and potentially increases value for remaining shareholders
- Company maintains legal rights to pursue additional value recovery from non-settling former officers
- Indication of potential corporate governance issues with former Canadian subsidiary officers
- Possible legal expenses ahead for pursuing claims against non-settling former officers
All legal options remain under consideration regarding the actions of former SRx Canada officers
TAMPA, Fla., Aug. 29, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company�), a leading global health and wellness company, today announced the cancellation of an additional 350,000 shares, increasing the total number of shares canceled to over 19 million shares of its capital stock. The cancellation was executed under a Settlement, Share Forfeiture and Mutual Release Agreement with certain founders and former officers of its Canadian subsidiary, SRx Health Solutions (Canada), Inc., and related parties.
Under to the Settlement Agreement, certain founders and former officers of SRx Canada have forfeited approximately 19 million exchangeable shares, which were originally issued as part of the Company’s acquisition of SRx Canada. In return, the Company agreed to release these parties from specific claims.
The Company intends to explore all available legal remedies against former officers of SRx Canada who are not parties to the Settlement Agreement in order to recover any lost value on behalf of its stockholders.
About SRx Health Solutions, Inc.
SRx Health Solutions Inc. is an integrated Canadian healthcare services provider that operates within the specialty healthcare industry. The SRx network extends across all ten Canadian provinces, making it one of the most accessible providers of comprehensive, integrated, and customized specialty healthcare services in the country. SRx combines years of industry knowledge, technology, and patient-centric focus to create strategies and solutions that consistently exceed client expectations and drive critical patient care initiatives aimed to improve the wellness of Canadians.� For more information on SRx Health Solutions Inc., please visit .
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe,� “may,� “estimate,� “continue,� “anticipate,� “intend,� “should,� “plan,� “could,� “target,� “potential,� “is likely,� “will,� “expect� and similar expressions, as they relate to us, are intended to identify forward-looking statements. The Company has based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Some or all of the results anticipated by these forward-looking statements may not be achieved. Further information on the Company’s risk factors is contained in our filings with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.
Company Contact:
SRx Health Solutions, Inc.
Kent Cunningham, Chief Executive Officer
Investor Contact:
KCSA Strategic Communications
Valter Pinto, Managing Director
T: 212-896-1254
